drugset / Trial / NCT00931710

Valsartan/Amlodipine As Compared to Losartan Treatment in Stage 2 Systolic Hypertension

NCT00931710

Phase 4 Completed 488 enrolled Novartis
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will compare the antihypertensive efficacy and safety of a valsartan/amlodipine-based treatment with a losartan-based treatment in patients with Stage 2 systolic hypertension (high blood pressure, mean systolic blood pressure greater than 160 and less than 200 mmHg).

Timeline

Start
2009-07
Primary completion
2010-01
Completion
2010-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 10 mg
Subject Hydrochlorothiazide Unknown 25 mg
Comparator Losartan Other / unclassified 100 mg
Subject Valsartan Small molecule 320 mg

Indications